<?xml version="1.0" encoding="UTF-8"?>
<!-- This sitemap was dynamically generated on April 8, 2026 at 1:28 PM by All in One SEO v4.9.5.1 - the original SEO plugin for WordPress. -->

<?xml-stylesheet type="text/xsl" href="https://cgxpwire.com/default-sitemap.xsl"?>

<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
	<channel>
		<title>cGxP.wire</title>
		<link><![CDATA[https://cgxpwire.com]]></link>
		<description><![CDATA[cGxP.wire]]></description>
		<lastBuildDate><![CDATA[Wed, 08 Apr 2026 10:27:18 +0000]]></lastBuildDate>
		<docs>https://validator.w3.org/feed/docs/rss2.html</docs>
		<atom:link href="https://cgxpwire.com/sitemap.rss" rel="self" type="application/rss+xml" />
		<ttl><![CDATA[60]]></ttl>

		<item>
			<guid><![CDATA[https://cgxpwire.com/pharma/biocon-launches-denosumab-biosimilars-in-u-s/]]></guid>
			<link><![CDATA[https://cgxpwire.com/pharma/biocon-launches-denosumab-biosimilars-in-u-s/]]></link>
			<title>Biocon Launches Denosumab Biosimilars in U.S.</title>
			<pubDate><![CDATA[Wed, 08 Apr 2026 10:27:18 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/bioora-and-octane-expand-car-t-manufacturing-globally/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/bioora-and-octane-expand-car-t-manufacturing-globally/]]></link>
			<title>BioOra and Octane Expand CAR-T Manufacturing Globally</title>
			<pubDate><![CDATA[Wed, 08 Apr 2026 09:32:19 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/alloy-and-biogen-partner-on-antisense-drug-platform/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/alloy-and-biogen-partner-on-antisense-drug-platform/]]></link>
			<title>Alloy and Biogen Partner on Antisense Drug Platform</title>
			<pubDate><![CDATA[Wed, 08 Apr 2026 09:15:20 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/technology/lumonus-and-msk-advance-ai-radiation-planning/]]></guid>
			<link><![CDATA[https://cgxpwire.com/technology/lumonus-and-msk-advance-ai-radiation-planning/]]></link>
			<title>Lumonus and MSK Advance AI Radiation Planning</title>
			<pubDate><![CDATA[Wed, 08 Apr 2026 09:03:57 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/resolve-and-pasteur-advance-cfrna-autoimmune-research/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/resolve-and-pasteur-advance-cfrna-autoimmune-research/]]></link>
			<title>Resolve and Pasteur Advance cfRNA Autoimmune Research</title>
			<pubDate><![CDATA[Wed, 08 Apr 2026 08:42:39 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/bioaffinity-showcases-cypath-lung-at-cleveland-clinic/]]></guid>
			<link><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/bioaffinity-showcases-cypath-lung-at-cleveland-clinic/]]></link>
			<title>bioAffinity Showcases CyPath Lung at Cleveland Clinic</title>
			<pubDate><![CDATA[Wed, 08 Apr 2026 08:33:58 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/johnson-johnson-launches-varipulse-pro-in-europe/]]></guid>
			<link><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/johnson-johnson-launches-varipulse-pro-in-europe/]]></link>
			<title>Johnson &amp; Johnson Launches VARIPULSE Pro in Europe</title>
			<pubDate><![CDATA[Wed, 08 Apr 2026 08:28:40 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/pharma/apotex-wins-approval-for-denoza-biosimilar-in-canada/]]></guid>
			<link><![CDATA[https://cgxpwire.com/pharma/apotex-wins-approval-for-denoza-biosimilar-in-canada/]]></link>
			<title>Apotex Wins Approval for DENOZA Biosimilar in Canada</title>
			<pubDate><![CDATA[Wed, 08 Apr 2026 08:22:37 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/singlomics-doses-first-patient-in-dxp-106-trial/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/singlomics-doses-first-patient-in-dxp-106-trial/]]></link>
			<title>Singlomics Doses First Patient in DXP-106 Trial</title>
			<pubDate><![CDATA[Wed, 08 Apr 2026 08:00:26 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/nanoviricides-files-measles-drug-for-rare-disease-status/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/nanoviricides-files-measles-drug-for-rare-disease-status/]]></link>
			<title>NanoViricides Files Measles Drug for Rare Disease Status</title>
			<pubDate><![CDATA[Wed, 08 Apr 2026 07:51:30 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/fortitude-advances-t-cell-therapy-for-axial-disease/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/fortitude-advances-t-cell-therapy-for-axial-disease/]]></link>
			<title>Fortitude Advances T-Cell Therapy for Axial Disease</title>
			<pubDate><![CDATA[Wed, 08 Apr 2026 07:43:12 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/mergers-acquisitions/gilead-acquires-tubulis-to-boost-oncology-pipeline/]]></guid>
			<link><![CDATA[https://cgxpwire.com/mergers-acquisitions/gilead-acquires-tubulis-to-boost-oncology-pipeline/]]></link>
			<title>Gilead Acquires Tubulis to Boost Oncology Pipeline</title>
			<pubDate><![CDATA[Wed, 08 Apr 2026 07:34:05 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/government/als-research-at-risk-from-proposed-fy27-budget-cuts/]]></guid>
			<link><![CDATA[https://cgxpwire.com/government/als-research-at-risk-from-proposed-fy27-budget-cuts/]]></link>
			<title>ALS Research at Risk from Proposed FY27 Budget Cuts</title>
			<pubDate><![CDATA[Wed, 08 Apr 2026 06:55:22 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/artivion-secures-fda-approval-for-nexus-aortic-system/]]></guid>
			<link><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/artivion-secures-fda-approval-for-nexus-aortic-system/]]></link>
			<title>Artivion Secures FDA Approval for NEXUS Aortic System</title>
			<pubDate><![CDATA[Wed, 08 Apr 2026 06:37:22 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/venture-capital-fund/kiora-raises-24m-to-advance-retinal-therapies/]]></guid>
			<link><![CDATA[https://cgxpwire.com/venture-capital-fund/kiora-raises-24m-to-advance-retinal-therapies/]]></link>
			<title>Kiora Raises $24M to Advance Retinal Therapies</title>
			<pubDate><![CDATA[Wed, 08 Apr 2026 06:27:48 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/pharma/shionogi-shows-strong-fetroja-real-world-effectiveness/]]></guid>
			<link><![CDATA[https://cgxpwire.com/pharma/shionogi-shows-strong-fetroja-real-world-effectiveness/]]></link>
			<title>Shionogi Shows Strong Fetroja Real-World Effectiveness</title>
			<pubDate><![CDATA[Wed, 08 Apr 2026 06:17:52 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/alzamend-reports-phase-ii-al001-brain-data-gains/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/alzamend-reports-phase-ii-al001-brain-data-gains/]]></link>
			<title>Alzamend Reports Phase II AL001 Brain Data Gains</title>
			<pubDate><![CDATA[Wed, 08 Apr 2026 06:12:46 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/nurexone-strengthens-gmp-exosome-supply-via-bioxtek/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/nurexone-strengthens-gmp-exosome-supply-via-bioxtek/]]></link>
			<title>NurExone Strengthens GMP Exosome Supply via BioXtek</title>
			<pubDate><![CDATA[Wed, 08 Apr 2026 05:35:29 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/pharma/savara-molbreevi-maa-accepted-by-uk-mhra-for-pap/]]></guid>
			<link><![CDATA[https://cgxpwire.com/pharma/savara-molbreevi-maa-accepted-by-uk-mhra-for-pap/]]></link>
			<title>Savara MOLBREEVI MAA Accepted by UK MHRA for PAP</title>
			<pubDate><![CDATA[Tue, 07 Apr 2026 16:22:19 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/pharma/acadia-expands-daybue-stix-access-for-rett-syndrome/]]></guid>
			<link><![CDATA[https://cgxpwire.com/pharma/acadia-expands-daybue-stix-access-for-rett-syndrome/]]></link>
			<title>Acadia Expands DAYBUE STIX Access for Rett Syndrome</title>
			<pubDate><![CDATA[Tue, 07 Apr 2026 16:13:49 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/cgbio-secures-38m-deals-at-imcas-2025-expansion-boost/]]></guid>
			<link><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/cgbio-secures-38m-deals-at-imcas-2025-expansion-boost/]]></link>
			<title>CGBIO Secures $38M Deals at IMCAS 2025 Expansion Boost</title>
			<pubDate><![CDATA[Tue, 07 Apr 2026 10:29:09 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/curateq-reports-positive-phase-3-results-for-bp11-biosimilar/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/curateq-reports-positive-phase-3-results-for-bp11-biosimilar/]]></link>
			<title>CuraTeQ Reports Positive Phase 3 Results for BP11 Biosimilar</title>
			<pubDate><![CDATA[Tue, 07 Apr 2026 10:23:28 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/sanofi-lunsekimig-shows-strong-phase-2-results-in-asthma/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/sanofi-lunsekimig-shows-strong-phase-2-results-in-asthma/]]></link>
			<title>Sanofi Lunsekimig Shows Strong Phase 2 Results in Asthma</title>
			<pubDate><![CDATA[Tue, 07 Apr 2026 10:18:08 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/renovare-therapeutics-launches-with-33-5m-arpa-h-support/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/renovare-therapeutics-launches-with-33-5m-arpa-h-support/]]></link>
			<title>Renovare Therapeutics Launches with $33.5M ARPA-H Support</title>
			<pubDate><![CDATA[Tue, 07 Apr 2026 10:14:13 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/clinical-trial-research/praxis-precision-medicines-reports-strong-elsunersen-trial/]]></guid>
			<link><![CDATA[https://cgxpwire.com/clinical-trial-research/praxis-precision-medicines-reports-strong-elsunersen-trial/]]></link>
			<title>Praxis Precision Medicines Reports Strong Elsunersen Trial</title>
			<pubDate><![CDATA[Tue, 07 Apr 2026 07:42:20 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/clinical-trial-research/oncolytics-advances-pelareorep-toward-anal-cancer-approval/]]></guid>
			<link><![CDATA[https://cgxpwire.com/clinical-trial-research/oncolytics-advances-pelareorep-toward-anal-cancer-approval/]]></link>
			<title>Oncolytics Advances Pelareorep Toward Anal Cancer Approval</title>
			<pubDate><![CDATA[Tue, 07 Apr 2026 07:35:04 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/clinical-trial-research/medicus-pharma-advances-teverelix-phase-2-fda-strategy/]]></guid>
			<link><![CDATA[https://cgxpwire.com/clinical-trial-research/medicus-pharma-advances-teverelix-phase-2-fda-strategy/]]></link>
			<title>Medicus Pharma Advances Teverelix Phase 2 FDA Strategy</title>
			<pubDate><![CDATA[Tue, 07 Apr 2026 07:28:24 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/egg-medical-launches-eggnest-flex-apron-free-protection/]]></guid>
			<link><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/egg-medical-launches-eggnest-flex-apron-free-protection/]]></link>
			<title>Egg Medical Launches EggNest Flex Apron-Free Protection</title>
			<pubDate><![CDATA[Tue, 07 Apr 2026 06:37:17 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/bora-biologics-achieves-2000l-scale-up-milestone-in-us/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/bora-biologics-achieves-2000l-scale-up-milestone-in-us/]]></link>
			<title>Bora Biologics Achieves 2,000L Scale-Up Milestone in US</title>
			<pubDate><![CDATA[Tue, 07 Apr 2026 06:30:03 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/clinical-trial-research/amgen-tepezza-subcutaneous-trial-shows-strong-phase-3-results/]]></guid>
			<link><![CDATA[https://cgxpwire.com/clinical-trial-research/amgen-tepezza-subcutaneous-trial-shows-strong-phase-3-results/]]></link>
			<title>Amgen TEPEZZA Subcutaneous Trial Shows Strong Phase 3 Results</title>
			<pubDate><![CDATA[Tue, 07 Apr 2026 06:21:28 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/clinical-trial-research/affinia-therapeutics-wins-canada-nod-for-aftx-201-trial/]]></guid>
			<link><![CDATA[https://cgxpwire.com/clinical-trial-research/affinia-therapeutics-wins-canada-nod-for-aftx-201-trial/]]></link>
			<title>Affinia Therapeutics Wins Canada Nod for AFTX-201 Trial</title>
			<pubDate><![CDATA[Tue, 07 Apr 2026 06:17:10 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/clinical-trial-research/adagene-reports-strong-muzastotug-keytruda-crc-data/]]></guid>
			<link><![CDATA[https://cgxpwire.com/clinical-trial-research/adagene-reports-strong-muzastotug-keytruda-crc-data/]]></link>
			<title>Adagene Reports Strong Muzastotug KEYTRUDA CRC Data</title>
			<pubDate><![CDATA[Tue, 07 Apr 2026 06:09:17 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/clinical-trial-research/ideaya-biosciences-doses-first-patient-in-ide574-trial/]]></guid>
			<link><![CDATA[https://cgxpwire.com/clinical-trial-research/ideaya-biosciences-doses-first-patient-in-ide574-trial/]]></link>
			<title>IDEAYA Biosciences Doses First Patient in IDE574 Trial</title>
			<pubDate><![CDATA[Tue, 07 Apr 2026 06:02:16 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/clinical-trial-research/akeso-cadonilimab-combo-delivers-strong-nsclc-trial-results/]]></guid>
			<link><![CDATA[https://cgxpwire.com/clinical-trial-research/akeso-cadonilimab-combo-delivers-strong-nsclc-trial-results/]]></link>
			<title>Akeso Cadonilimab Combo Delivers Strong NSCLC Trial Results</title>
			<pubDate><![CDATA[Tue, 07 Apr 2026 05:57:10 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/delcath-chemosat-gains-esmo-guideline-recognition-boost/]]></guid>
			<link><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/delcath-chemosat-gains-esmo-guideline-recognition-boost/]]></link>
			<title>Delcath CHEMOSAT Gains ESMO Guideline Recognition Boost</title>
			<pubDate><![CDATA[Tue, 07 Apr 2026 05:47:11 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/clinical-trial-research/tenvie-therapeutics-doses-first-patient-in-tnv262-trial/]]></guid>
			<link><![CDATA[https://cgxpwire.com/clinical-trial-research/tenvie-therapeutics-doses-first-patient-in-tnv262-trial/]]></link>
			<title>Tenvie Therapeutics Doses First Patient in TNV262 Trial</title>
			<pubDate><![CDATA[Tue, 07 Apr 2026 05:42:33 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/mergers-acquisitions/neurocrine-acquires-soleno-to-boost-rare-disease-portfolio/]]></guid>
			<link><![CDATA[https://cgxpwire.com/mergers-acquisitions/neurocrine-acquires-soleno-to-boost-rare-disease-portfolio/]]></link>
			<title>Neurocrine Acquires Soleno to Boost Rare Disease Portfolio</title>
			<pubDate><![CDATA[Tue, 07 Apr 2026 05:23:00 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/adagene-incyte-drive-new-mss-crc-immunotherapy-study/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/adagene-incyte-drive-new-mss-crc-immunotherapy-study/]]></link>
			<title>Adagene &amp; Incyte Drive New MSS CRC Immunotherapy Study</title>
			<pubDate><![CDATA[Tue, 07 Apr 2026 05:12:51 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/co-diagnostics-expands-gmp-facility-in-saudi-arabia/]]></guid>
			<link><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/co-diagnostics-expands-gmp-facility-in-saudi-arabia/]]></link>
			<title>Co-Diagnostics Expands GMP Facility in Saudi Arabia</title>
			<pubDate><![CDATA[Mon, 06 Apr 2026 10:35:50 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/cosmetics/kama-ayurveda-launches-sandanya-anti-blemish-range/]]></guid>
			<link><![CDATA[https://cgxpwire.com/cosmetics/kama-ayurveda-launches-sandanya-anti-blemish-range/]]></link>
			<title>Kama Ayurveda Launches Sandanya Anti-Blemish Range</title>
			<pubDate><![CDATA[Mon, 06 Apr 2026 09:54:22 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/relay-therapeutics-advances-zovegalisib-clinical-data/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/relay-therapeutics-advances-zovegalisib-clinical-data/]]></link>
			<title>Relay Therapeutics Advances Zovegalisib Clinical Data</title>
			<pubDate><![CDATA[Mon, 06 Apr 2026 09:41:30 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/food/fda-investigates-e-coli-outbreak-linked-to-raw-cheese/]]></guid>
			<link><![CDATA[https://cgxpwire.com/food/fda-investigates-e-coli-outbreak-linked-to-raw-cheese/]]></link>
			<title>FDA Investigates E. coli Outbreak Linked to Raw Cheese</title>
			<pubDate><![CDATA[Mon, 06 Apr 2026 09:23:40 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/gc-biopharma-enhances-ivig-safety-with-fxi-detection/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/gc-biopharma-enhances-ivig-safety-with-fxi-detection/]]></link>
			<title>GC Biopharma Enhances IVIG Safety with FXI Detection</title>
			<pubDate><![CDATA[Mon, 06 Apr 2026 09:19:31 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/food/usda-fsis-updates-food-safety-policies-and-sampling-data/]]></guid>
			<link><![CDATA[https://cgxpwire.com/food/usda-fsis-updates-food-safety-policies-and-sampling-data/]]></link>
			<title>USDA FSIS Updates Food Safety Policies and Sampling Data</title>
			<pubDate><![CDATA[Mon, 06 Apr 2026 09:12:07 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/concept-medical-reports-sirpad-trial-success-in-pad/]]></guid>
			<link><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/concept-medical-reports-sirpad-trial-success-in-pad/]]></link>
			<title>Concept Medical Reports SirPAD Trial Success in PAD</title>
			<pubDate><![CDATA[Mon, 06 Apr 2026 09:04:32 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/restor3d-launches-aeros-modular-stem-ankle-system/]]></guid>
			<link><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/restor3d-launches-aeros-modular-stem-ankle-system/]]></link>
			<title>restor3d Launches Aeros Modular Stem Ankle System</title>
			<pubDate><![CDATA[Mon, 06 Apr 2026 06:37:20 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/henlius-secures-nmpa-ind-for-hlx319-breast-cancer-drug/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/henlius-secures-nmpa-ind-for-hlx319-breast-cancer-drug/]]></link>
			<title>Henlius Secures NMPA IND for HLX319 Breast Cancer Drug</title>
			<pubDate><![CDATA[Mon, 06 Apr 2026 06:30:51 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/cu-anschutz-secures-fda-ind-for-car-t-cell-therapy/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/cu-anschutz-secures-fda-ind-for-car-t-cell-therapy/]]></link>
			<title>CU Anschutz Secures FDA IND for CAR T-Cell Therapy</title>
			<pubDate><![CDATA[Mon, 06 Apr 2026 06:22:29 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/canwell-pharma-secures-fda-ind-for-can016-adc-trial/]]></guid>
			<link><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/canwell-pharma-secures-fda-ind-for-can016-adc-trial/]]></link>
			<title>CanWell Pharma Secures FDA IND for CAN016 ADC Trial</title>
			<pubDate><![CDATA[Mon, 06 Apr 2026 06:09:34 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/allevion-medical-gains-fda-510k-for-vantage-system/]]></guid>
			<link><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/allevion-medical-gains-fda-510k-for-vantage-system/]]></link>
			<title>Allevion Medical Gains FDA 510(k) for Vantage System</title>
			<pubDate><![CDATA[Mon, 06 Apr 2026 05:58:59 +0000]]></pubDate>
		</item>
				</channel>
</rss>
